Nancy M Garcia

Title: Nancy M Garcia: Innovator in Apoptosis and Leukemia Detection

Introduction

Nancy M Garcia is a prominent inventor based in Miami, FL (US). She has made significant contributions to the fields of apoptosis monitoring and leukemia detection. With a total of 2 patents, her work has the potential to impact medical diagnostics and treatment strategies.

Latest Patents

One of her latest patents is titled "Method and reagent for monitoring apoptosis and distinguishing apoptosis." This invention addresses the long-standing need to determine the stage or pathway of cysteine proteases in a single cell assay. The method and assay reagents developed by Garcia allow for the determination of enzyme activity and its relation to the apoptotic pathway. Additionally, this method can distinguish apoptotic activity from necrotic activity.

Another significant patent is "Identification of blast cells in a leukocyte cell preparation." This invention focuses on the necessity to detect blast cells in patient samples to determine appropriate treatment regimes for leukemia. The method and assay reagents enable the identification of blast cells in a fluid sample, providing a quicker determination than prior art methods.

Career Highlights

Nancy M Garcia is associated with Coulter International Corporation, where she applies her expertise in developing innovative solutions for medical diagnostics. Her work has garnered attention for its practical applications in healthcare.

Collaborations

Some of her notable coworkers include Eileen Landrum and Adry Galiounghi, who contribute to the collaborative environment at Coulter International Corporation.

Conclusion

Nancy M Garcia's contributions to the fields of apoptosis and leukemia detection exemplify her innovative spirit and dedication to improving medical diagnostics. Her patents reflect a commitment to advancing healthcare technology and enhancing patient outcomes.